Data from the ongoing phase Ib/II clinical trial of sulfatinib in patients with advanced neuroendocrine tumours (“NET”) was presented at the 14th Annual Conference of European Neuroendocrine Tumour Society (“ENETS”), held in Barcelona,...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2n0XnkX
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Publication date: October 2017 Source: International Journal of Biological Macromolecules, Volume 103 Author(s): Mingan Yu, Duqiang Liu, ...
-
Abstract Endurance exercise generates CO 2 via aerobic metabolism; however, its role remains unclear. Exogenous CO 2 by transcutaneous d...
-
FS Teni, AS Surur, A Hailemariam, A Aye, G Mitiku, AE Gurmu, B Tessema Annals of Medical and Health Sciences Research 2015 5(6):454-460 ...
-
Abstract Background Studies exploring the association between physical activity, screen time and sleep and pain usually focus on a limit...
-
RT @caonline : The role of extranodal extension in staging head and neck cancers: http://ift.tt/2qV1As1 #hncsm https://t.co/MxlLX4Olo6 f...
-
One third of adult patients with orthognathic surgery of a prognathic or retrognathic mandible show relapse. The sagittal split osteotomy of...
-
Abstract This paper analyzes the most and least used upper limb aquatic equipment for hydrotherapy/hydro kinesiology specialists in the tr...
-
Abstract Wheat germ has an important enzymatic activity, being lipases the enzymes which cause the highest impact in the reduction of shelf...
-
Medicine by Alexandros G. Sfakianakis BioMed Research International BioMed Research InternationalTanshinone IIA Alleviates CCL2-Induced Le...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου